Registration
|
08:00 - 08:55 |
Welcome note from MarketsandMarkets
|
08:55 - 09:00 |
Opening Remarks from the Chairman
Ronan Murphy , Assciate Editor, Clinical Epigenetics , Dublin City University
|
09:00 - 09:05 |
DEVELOPMENT OF EPIGENETICS |
Emerging Portfolio of Novel Epigenetic Inhibitors
Daniel Dransfield, Vice President, Biology, Epizyme
|
09:05 - 09:40 |
High-resolution economical profiling of epigenetic DNA modifications using TOP-seq
Saulius Klimasauskas, Director and Distinguished Professor, Institute of Biotechnology, Vilnius University
|
09:40 - 10:15 |
Robst Sample Preparation Solutions for Chromatin-based Applications
Angela Garding, Field Application Scientist, Covaris
|
10:15 - 10:45 |
Morning Refreshments | Poster Presentations | One-to-One Networking
|
10:45 - 11:35 |
The Potential of Select BET Inhibition for High Risk Vascular Diseases
Kenneth Lebioda, Senior Vice President, Business & Corporate Development, Reservlogix
|
11:35 - 12:05 |
Importance of investigating epigenetic alterations for industry and regulators
Rémi Terranova , Principle Investigator, Preclinical safety, Novartis Institutes for BioMedical Research, Switz
|
12:05 - 12:40 |
Drugging transcription: Progress and potential for treating human immune dysfunction
Inma Rioja , Senior Director & Portfolio Research Lead at Epige, GSK
|
12:40 - 13:10 |
Lunch | Poster Presentations | One-to-One Networking
|
13:10 - 14:10 |
TRANSLATIONAL EPIGENETICS |
Development of novel therapeutic anticancer approach with HDAC inhibitors: from the bench to the bedside
Alfredo Budillon , Chief Experimental Pharmacology Unit Department of, Istituto Nazionale tumori G. Pascale
|
14:10 - 14:45 |
Selective’ targeting of transcriptional scaffolding
Panagis Filippakopoulos , Associate Professor, Structural Genomics Consortiu, University of Oxford
|
14:45 - 15:20 |
Evening Refreshments | Poster Presentations | One-to-One Networking
|
15:20 - 16:10 |
Platelets: Functional biomarkers of epigenetic drift
Ronan Murphy , Assciate Editor, Clinical Epigenetics , Dublin City University
|
16:10 - 16:45 |
Making sense of disease-linked non-coding mutations
Mikhail Spivakov , Group leader and Honorary Senior Lecturer, MRC Lon, Imperial College
|
16:45 - 17:20 |
Probing HDACs and bromodomains in cancer with small molecule designer libraries
John Spencer, Professor, Bioorganic Chemistry, University of Sussex
|
17:20 - 17:55 |
Closing Remarks by the Chair
|
17:55 - 18:00 |
End of Day 1
|
18:00 - 18:10 |
Drink Reception & Networking
|
18:00 - 19:00 |